PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
07-Aug-2024 CLINIGEN ACQUIRES KINESYS CONSULTING TO BOLSTER REGULATORY AFFAIRS EXPERTISE Clinigen
07-Aug-2024 XF-73 treatment of MRSA burn wound infection prevents bacterial invasion of the bloodstream Destiny Pharma plc
07-Aug-2024 CellProthera begins long-term observational study to demonstrate safety and efficacy of ProtheraCytes® cell therapy in acute myocardial infarction CellProthera
07-Aug-2024 New results from AlzeCure's pain project TrkA-NAM presented at the pain conference IASP 2024 AlzeCure Pharma AB
07-Aug-2024 Release Therapeutics Secures CHF 3.3 Million in Seed Funding Release Therapeutics
07-Aug-2024 Velocity appoints ICON exec Rachael Buck Ph.D. as Head of U.K. Velocity Clinical Research
07-Aug-2024 Kyowa Kirin International and NewBridge Pharmaceuticals enter into agreement to improve access to medicines for rare disease patients across Middle East and North Africa Kyowa Kirin International
07-Aug-2024 Lindus Health Unveils “All-in-One Dermatology CRO” Offering for Dermatology Clinical Trials Lindus Health
06-Aug-2024 Adoption of ICH E6 (R3) is Coming Pharma Lessons
06-Aug-2024 Clinion Wins The Clinical Trials Arena Excellence Award 2024 for Innovation Clinion Inc
01-Aug-2024 Transgene strengthens its balance sheet via equity conversion of current account advance from TSGH Transgene
01-Aug-2024 New number of shares and votes in Moberg Pharma AB (publ) Moberg Pharma
01-Aug-2024 Lundbeck and Takeda modify the collaboration agreement for Trintellix in the U.S H. Lundbeck A/S
01-Aug-2024 Eisai present clinical data for continuous treatment with lecanemab at The Alzheimer’s Association International Conference 2024 Eisai
01-Aug-2024 As blood stock shortage crisis continues, less than half of Brits know their blood type, says expert London Medical Laboratory
01-Aug-2024 Novo Holdings Invests in UK-Listed Oxford Nanopore Technologies Novo Holdings
01-Aug-2024 INDEPENDENT PARSORTIX STUDY HIGHLIGHTS BENEFITS OF COMBINED DNA ANALYSIS IN MELANOMA ANGLE plc
01-Aug-2024 GenesisCare UK Strengthens Board with Appointment of Three Non-Executive Directors GenesisCare UK
30-Jul-2024 Clinical Lung Cancer Publishes Study: 93% of Oncologists Adjust Treatment Recommendations with OncoHost’s PROphetNSCLC™ Test PROphetNSCLC™
30-Jul-2024 Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation Pierre Fabre Laboratories